Mechanisms and functions of p38 MAPK signalling

Biochemical Journal

Volumn 429, Issue 3, 2010, Pages 403-417

  Cuadrado, Ana ^a   Nebreda, Angel R ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

Cell regulation; Mitogen activated protein kinase (MAPK); p38; Phosphorylation; Signalling; Stress response

Indexed keywords

CELL REGULATION; MITOGEN ACTIVATED PROTEIN KINASE; P38; SIGNALLING; STRESS RESPONSE;

PHOSPHORYLATION;

PHYSIOLOGICAL MODELS;

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SCAFFOLD PROTEIN;

CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STRESS; ANIMAL; CELL FRACTIONATION; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME ACTIVATION; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; SUBSTRATE SPECIFICITY;

EID: 77955059513     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20100323     Document Type: Review

References (172)

1. Nebreda, A. R. and Porras, A. (2000) p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25, 257-260
2. Ono, K. and Han, J. (2000) The p38 signal transduction pathway: activation and function. Cell. Signalling 12, 1-13 (Pubitemid 30017963)
3. Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869
4. Cuenda, A. and Rousseau, S. (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773, 1358-1375
5. Han, J., Lee, J.-D., Bibbs, L. and Ulevitch, R. J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811
6. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W. et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746
7. Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T. and Nebreda, A. R. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78, 1027-1037
8. Freshney, N. W., Rawlinson, L., Guesdon, F., Jones, E., Cowley, S., Hsuan, J. and Saklatvala, J. (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78, 1039-1049 (Pubitemid 24292331)
9. Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J. A., Lin, S. and Han, J. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271, 17920-17926
10. Lechner, C., Zahalka, M. A., Giot, J.-F., Moller, N. P. H. and Ullrich, A. (1996) ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc. Natl. Acad. Sci. U.S.A. 93, 4355-4359
11. Mertens, S., Craxton, M. and Goedert, M. (1996) SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS Lett. 383, 273-276 (Pubitemid 26104075)
12. Goedert, M., Cuenda, A., Craxton, M., Jakes, R. and Cohen, P. (1997) Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6): comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16, 3563-3571
13. Jiang, Y., Gram, H., Zhao, M., New, L., Gu, J., Feng, L., Di Padova, F., Ulevitch, R. J. and Han, J. (1997) Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ. J. Biol. Chem. 272, 30122-30128
14. Enslen, H., Raingeaud, J. and Davis, R. J. (1998) Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273, 1741-1748
15. Sabio, G., Arthur, J. S., Kuma, Y., Peggie, M., Carr, J., Murray-Tait, V., Centeno, F., Goedert, M., Morrice, N. A. and Cuenda, A. (2005) p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24, 1134-1145 (Pubitemid 40516597)
16. Casar, B., Sanz-Moreno, V., Yazicioglu, M. N., Rodriguez, J., Berciano, M. T., Lafarga, M., Cobb, M. H. and Crespo, P. (2007) Mxi2 promotes stimulus-independent ERK nuclear translocation. EMBO J. 26, 635-646
17. Yagasaki, Y., Sudo, T. and Osada, H. (2004) Exip, a splicing variant of p38α, participates in interleukin-1 receptor proximal complex and downregulates NF-κB pathway. FEBS Lett. 575, 136-140
18. Wrobleski, S. T. and Doweyko, A. M. (2005) Structural comparison of p38 inhibitor-protein complexes: a review of recent p38 inhibitors having unique binding interactions. Curr. Top. Med. Chem. 5, 1005-1016
19. ter Haar, E., Prabhakar, P., Liu, X. and Lepre, C. (2007) Crystal structure of the p38α-MAPKAP kinase 2 heterodimer. J. Biol. Chem. 282, 9733-9739
20. White, A., Pargellis, C. A., Studts, J. M., Werneburg, B. G. and Farmer, 2nd, B. T. (2007) Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc. Natl. Acad. Sci. U.S.A. 104, 6353-6358
21. Patel, S. B., Cameron, P. M., O'Keefe, S. J., Frantz-Wattley, B., Thompson, J., O'Neill, E. A., Tennis, T., Liu, L., Becker, J. W. and Scapin, G. (2009) The three-dimensional structure of MAP kinase p38β: different features of the ATP-binding site in p38β compared with p38α. Acta Crystallogr. Sect. D Biol. Crystallogr. 65, 777-785
22. Bellon, S., Fitzgibbon, M. J., Fox, T., Hsiao, H. M. and Wilson, K. P. (1999) The structure of phosphorylated p38γ is monomeric and reveals a conserved activation-loop conformation. Structure 7, 1057-1065
23. Alonso, G., Ambrosino, C., Jones, M. and Nebreda, A. R. (2000) Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J. Biol. Chem. 275, 40641-40648
24. Doza, N. Y., Cuenda, A., Thomas, G. M., Cohen, P. and Nebreda, A. R. (1995) Activation of the MAP kinase homologue RK requires the phosphorylation of Thr-180 and Tyr-182 and both residues are phosphorylated in chemically stressed KB cells. FEBS Lett. 364, 223-228
25. Brancho, D., Tanaka, N., Jaeschke, A., Ventura, J. J., Kelkar, N., Tanaka, Y., Kyuuma, M., Takeshita, T., Flavell, R. A. and Davis, R. J. (2003) Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17, 1969-1978 (Pubitemid 36999324)
26. Zhang, J., Shen, B. and Lin, A. (2007) Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacol. Sci. 28, 286-295
27. MAPK isoforms by MKK6 and MKK3. Cell. Signalling 22, 660-667
28. Min, X., Akella, R., He, H., Humphreys, J. M., Tsutakawa, S. E., Lee, S. J., Tainer, J. A., Cobb, M. H. and Goldsmith, E. J. (2009) The structure of the MAP2K MEK6 reveals an autoinhibitory dimer. Structure 17, 96-104
29. Cuevas, B. D., Abell, A. N. and Johnson, G. L. (2007) Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 26, 3159-3171
30. Zhuang, Z. H., Zhou, Y., Yu, M. C., Silverman, N. and Ge, B. X. (2006) Regulation of Drosophila p38 activation by specific MAP2 kinase and MAP3 kinase in response to different stimuli. Cell. Signalling 18, 441-448
31. Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A. and Nebreda, A. R. (2007) p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11, 191-205
32. Matsukawa, J., Matsuzawa, A., Takeda, K. and Ichijo, H. (2004) The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. (Tokyo) 136, 261-265
33. Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bulow, V., Schuster, N., Zhang, S., Heldin, C. H. and Landstrom, M. (2008) The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat. Cell Biol. 10, 1199-1207
34. Yamashita, M., Fatyol, K., Jin, C., Wang, X., Liu, Z. and Zhang, Y. E. (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol. Cell 31, 918-924
35. Matsuzawa, A., Tseng, P. H., Vallabhapurapu, S., Luo, J. L., Zhang, W., Wang, H., Vignali, D. A., Gallagher, E. and Karin, M. (2008) Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663-668
36. Salvador, J. M., Mittelstadt, P. R., Guszczynski, T., Copeland, T. D., Yamaguchi, H., Appella, E., Fornace, Jr, A. J. and Ashwell, J. D. (2005) Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat. Immunol. 6, 390-395
37. Salvador, J. M., Mittelstadt, P. R., Belova, G. I., Fornace, Jr, A. J. and Ashwell, J. D. (2005) The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway. Nat. Immunol. 6, 396-402
38. 323 phosphorylation prevents T-cell receptor-mediated p38α activation and impairs interferon-γ production. Blood 113, 2229-2237
39. Ge, B., Gram, H., Di Padova, F., Huang, B., New, L., Ulevitch, R. J., Luo, Y. and Han, J. (2002) MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α. Science 295, 1291-1294
40. Zhou, H., Zheng, M., Chen, J., Xie, C., Kolatkar, A. R., Zarubin, T., Ye, Z., Akella, R., Lin, S., Goldsmith, E. J. and Han, J. (2006) Determinants that control the specific interactions between TAB1 and p38α. Mol. Cell. Biol. 26, 3824-3834
41. Cheung, P. C., Campbell, D. G., Nebreda, A. R. and Cohen, P. (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 22, 5793-5805
42. Tanno, M., Bassi, R., Gorog, D. A., Saurin, A. T., Jiang, J., Heads, R. J., Martin, J. L., Davis, R. J., Flavell, R. A. and Marber, M. S. (2003) Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ. Res. 93, 254-261
43. Li, J., Miller, E. J., Ninomiya-Tsuji, J., Russell, 3rd, R. R. and Young, L. H. (2005) AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ. Res. 97, 872-879
44. Matsuyama, W., Faure, M. and Yoshimura, T. (2003) Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-β- activated protein kinase 1 binding protein 1β/p38α mitogen-activated protein kinase signaling cascade. J. Immunol. 171, 3520-3532
45. Kim, L., Del Rio, L., Butcher, B. A., Mogensen, T. H., Paludan, S. R., Flavell, R. A. and Denkers, E. Y. (2005) p38 MAPK autophosphorylation drives macrophage IL-12 production during intracellular infection. J. Immunol. 174, 4178-4184
46. Im, J. S. and Lee, J. K. (2008) ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7. J. Biol. Chem. 283, 25171-25177
47. Zhang, Y. Y., Mei, Z. Q., Wu, J. W. and Wang, Z. X. (2008) Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38α in different phosphorylation states. J. Biol. Chem. 283, 26591-26601
48. 180. Biochemistry 48, 2497-2504
49. 2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J. 28, 3196-3206
50. Le Guezennec, X. and Bulavin, D. V. (2010) WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem. Sci. 35, 109-114
51. 2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes. Mol. Cell. Biol. 29, 675-686
52. Zhu, Y., Li, H., Long, C., Hu, L., Xu, H., Liu, L., Chen, S., Wang, D. C. and Shao, F. (2007) Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. Mol. Cell 28, 899-913
53. Owens, D. M. and Keyse, S. M. (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26, 3203-3213
54. Ko, H. M., Oh, S. H., Bang, H. S., Kang, N. I., Cho, B. H., Im, S. Y. and Lee, H. K. (2009) Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1. J. Immunol. 182, 7957-7962
55. Yang, D., Xie, P., Guo, S. and Li, H. (2010) Induction of MAPK phosphatase-1 by hypothermia inhibits TNF-α-induced endothelial barrier dysfunction and apoptosis. Cardiovasc. Res. 85, 520-529
56. Maneechotesuwan, K., Yao, X., Ito, K., Jazrawi, E., Usmani, O. S., Adcock, I. M. and Barnes, P. J. (2009) Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med. 6, e1000076
57. Lin, Y. W., Chuang, S. M. and Yang, J. L. (2003) ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. J. Biol. Chem. 278, 21534-21541
58. Cao, W., Bao, C., Padalko, E. and Lowenstein, C. J. (2008) Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J. Exp. Med. 205, 1491-1503
59. Qian, F., Deng, J., Cheng, N., Welch, E. J., Zhang, Y., Malik, A. B., Flavell, R. A., Dong, C. and Ye, R. D. (2009) A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury. EMBO J. 28, 2896-2907
60. Good, M., Tang, G., Singleton, J., Remenyi, A. and Lim, W. A. (2009) The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation. Cell 136, 1085-1097
61. Uhlik, M. T., Abell, A. N., Johnson, N. L., Sun, W., Cuevas, B. D., Lobel-Rice, K. E., Horne, E. A., Dell'Acqua, M. L. and Johnson, G. L. (2003) Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5, 1104-1110
62. Morrison, D. K. and Davis, R. J. (2003) Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19, 91-118
63. Kelkar, N., Standen, C. L. and Davis, R. J. (2005) Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol. Cell. Biol. 25, 2733-2743
64. Kang, J. S., Bae, G. U., Yi, M. J., Yang, Y. J., Oh, J. E., Takaesu, G., Zhou, Y. T., Low, B. C. and Krauss, R. S. (2008) A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38α/β MAPK activity and myogenic differentiation. J. Cell Biol. 182, 497-507
65. Oh, J. E., Bae, G. U., Yang, Y. J., Yi, M. J., Lee, H. J., Kim, B. G., Krauss, R. S. and Kang, J. S. (2009) Cdo promotes neuronal differentiation via activation of the p38 mitogen-activated protein kinase pathway. FASEB J. 23, 2088-2099
66. Cuenda, A. and Cohen, P. (1999) Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274, 4341-4346
67. Tanaka, N., Kamanaka, M., Enslen, H., Dong, C., Wysk, M., Davis, R. J. and Flavell, R. A. (2002) Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis. EMBO Rep. 3, 785-791
68. Galan-Moya, E. M., Hernandez-Losa, J., Aceves Luquero, C. I., de la Cruz-Morcillo, M. A., Ramírez-Castillejo, C., Callejas-Valera, J. L., Arriaga, A., Aranburo, A. F., Ramón y Cajal, S., Gutkind, J. S. and Sánchez-Prieto, R. (2008) c-Abl activates p38 MAPK independently of its tyrosine kinase activity: implications in cisplatin-based therapy. Int. J. Cancer 122, 289-297
69. Marasa, B. S., Srikantan, S., Masuda, K., Abdelmohsen, K., Kuwano, Y., Yang, X., Martindale, J. L., Rinker-Schaeffer, C. W. and Gorospe, M. (2009) Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci. Signaling 2, ra69
70. Ahn, Y. H. and Kurie, J. M. (2009) MKK4/SEK1 is negatively regulated through a feedback loop involving the E3 ubiquitin ligase itch. J. Biol. Chem. 284, 29399-29404
71. Ronkina, N., Kotlyarov, A., Dittrich-Breiholz, O., Kracht, M., Hitti, E., Milarski, K., Askew, R., Marusic, S., Lin, L. L., Gaestel, M. and Telliez, J. B. (2007) The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol. Cell. Biol. 27, 170-181
72. Sudo, T., Kawai, K., Matsuzaki, H. and Osada, H. (2005) p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. Biochem. Biophys. Res. Commun. 337, 415-421
73. MAPK. Curr. Biol. 16, 2042-2047
74. Chopra, A. P., Boone, S. A., Liang, X. and Duesbery, N. S. (2003) Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J. Biol. Chem. 278, 9402-9406
75. Mukherjee, S., Keitany, G., Li, Y., Wang, Y., Ball, H. L., Goldsmith, E. J. and Orth, K. (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312, 1211-1214
76. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J. and Davis, R. J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426
77. Ben-Levy, R., Hooper, S., Wilson, R., Paterson, H. F. and Marshall, C. J. (1998) Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr. Biol. 8, 1049-1057
78. Wood, C. D., Thornton, T. M., Sabio, G., Davis, R. A. and Rincon, M. (2009) Nuclear localization of p38 MAPK in response to DNA damage. Int. J. Biol. Sci. 5, 428-437
79. Engel, K., Kotlyarov, A. and Gaestel, M. (1998) Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J. 17, 3363-3371 (Pubitemid 28279510)
80. Lu, G., Kang, Y. J., Han, J., Herschman, H. R., Stefani, E. and Wang, Y. (2006) TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling. J. Biol. Chem. 281, 6087-6095
81. Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R. and Anderton, B. H. (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3β. J. Neurochem. 74, 1587-1595
82. Gao, J., Davidson, M. K. and Wahls, W. P. (2009) Phosphorylation- independent regulation of Atf1-promoted meiotic recombination by stress-activated, p38 kinase Spc1 of fission yeast. PLoS ONE 4, e5533
83. Alepuz, P. M., de Nadal, E., Zapater, M., Ammerer, G. and Posas, F. (2003) Osmostress-induced transcription by Hot1 depends on a Hog1-mediated recruitment of the RNA Pol II. EMBO J. 22, 2433-2442
84. de Nadal, E. and Posas, F. (2010) Multilayered control of gene expression by stress-activated protein kinases. EMBO J. 29, 4-13
85. Fan, L., Yang, X., Du, J., Marshall, M., Blanchard, K. and Ye, X. (2005) A novel role of p38α MAPK in mitotic progression independent of its kinase activity. Cell Cycle 4, 1616-1624
86. Cheung, W. D. and Hart, G. W. (2008) AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J. Biol. Chem. 283, 13009-13020
87. Tang, J., Qi, X., Mercola, D., Han, J. and Chen, G. (2005) Essential role of p38γ in K-Ras transformation independent of phosphorylation. J. Biol. Chem. 280, 23910-23917
88. Tanoue, T., Adachi, M., Moriguchi, T. and Nishida, E. (2000) A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell Biol. 2, 110-116
89. Enslen, H. and Davis, R. J. (2001) Regulation of MAP kinases by docking domains. Biol. Cell 93, 5-14 (Pubitemid 33040855)
90. Biondi, R. M. and Nebreda, A. R. (2003) Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem. J. 372, 1-13
91. Mayor, Jr, F., Jurado-Pueyo, M., Campos, P. M. and Murga, C. (2007) Interfering with MAP kinase docking interactions: implications and perspective for the p38 route. Cell Cycle 6, 528-533
92. Chang, C. I., Xu, B. E., Akella, R., Cobb, M. H. and Goldsmith, E. J. (2002) Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 9, 1241-1249 (Pubitemid 34722303)
93. Roux, P. P. and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344
94. Bardwell, A. J., Frankson, E. and Bardwell, L. (2009) Selectivity of docking sites in MAPK kinases. J. Biol. Chem. 284, 13165-13173
95. 1-syntrophin: a mechanism for specific substrate recognition. J. Biol. Chem. 274, 12626-12631
96. Davidson, W., Frego, L., Peet, G. W., Kroe, R. R., Labadia, M. E., Lukas, S. M., Snow, R. J., Jakes, S., Grygon, C. A., Pargellis, C. and Werneburg, B. G. (2004) Discovery and characterization of a substrate selective p38α inhibitor. Biochemistry 43, 11658-11671
97. Arthur, J. S. (2008) MSK activation and physiological roles. Front. Biosci. 13, 5866-5879
98. Soloaga, A., Thomson, S., Wiggin, G. R., Rampersaud, N., Dyson, M. H., Hazzalin, C. A., Mahadevan, L. C. and Arthur, J. S. (2003) MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788-2797
99. Llanos, S., Cuadrado, A. and Serrano, M. (2009) MSK2 inhibits p53 activity in the absence of stress. Sci. Signaling 2, ra57
100. Shi, Y. and Gaestel, M. (2002) In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 383, 1519-1536
101. Mahalingam, M. and Cooper, J. A. (2001) Phosphorylation of mammalian eIF4E by Mnk1 and Mnk2: tantalizing prospects for a role in translation. Prog. Mol. Subcell. Biol. 27, 132-142
102. Zeng, Y., Sankala, H., Zhang, X. and Graves, P. R. (2008) Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem. J. 413, 429-436
103. S-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis. Nat. Immunol. 10, 918-926
104. Khurana, A., Nakayama, K., Williams, S., Davis, R. J., Mustelin, T. and Ronai, Z. (2006) Regulation of the ring finger E3 ligase Siah2 by p38 MAPK. J. Biol. Chem. 281, 35316-35326
105. Swat, A., Dolado, I., Rojas, J. M. and Nebreda, A. R. (2009) Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38α mitogen-activated protein kinase via Sprouty2 downregulation. Mol. Cell. Biol. 29, 3332-3343
106. Webber, J. L. and Tooze, S. A. (2010) Coordinated regulation of autophagy by p38α MAPK through mAtg9 and p38IP. EMBO J. 29, 27-40
107. Cavalli, V., Vilbois, F., Corti, M., Marcote, M. J., Tamura, K., Karin, M., Arkinstall, S. and Gruenberg, J. (2001) The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. Mol. Cell 7, 421-432
108. Mace, G., Miaczynska, M., Zerial, M. and Nebreda, A. R. (2005) Phosphorylation of EEA1 by p38 MAP kinase regulates μ opioid receptor endocytosis. EMBO J. 24, 3235-3246
109. Zwang, Y. and Yarden, Y. (2006) p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J. 25, 4195-4206 (Pubitemid 44435217)
110. Pinglong, X. and Derynck, R. (2010) Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol. Cell 37, 551-566
111. 777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus. Mol. Cell. Biol. 28, 4129-4141
112. Cip1 mRNA mediates the G1/S checkpoint. Mol. Cell. Biol. 29, 4341-4351
113. Perdiguero, E. and Muñoz-Canoves, P. (2008) Transcriptional regulation by the p38 MAPK signalling pathway in mammalian cells. Top. Curr. Genet. 20, 51-79
114. Geest, C. R., Buitenhuis, M., Laarhoven, A. G., Bierings, M. B., Bruin, M. C., Vellenga, E. and Coffer, P. J. (2009) p38 MAP kinase inhibits neutrophil development through phosphorylation of C/EBPα on serine 21. Stem Cells 27, 2271-2282
115. SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 69, 5664-5672
116. Corre, S., Primot, A., Baron, Y., Le Seyec, J., Goding, C. and Galibert, M. D. (2009) Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation. J. Biol. Chem. 284, 18851-18862
117. Saccani, S., Pantano, S. and Natoli, G. (2002) p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3, 69-75
118. Zhao, Q., Barakat, B. M., Qin, S., Ray, A., El-Mahdy, M. A., Wani, G., Arafa, E.-S., Mir, S. N., Wang, Q. E. and Wani, A. A. (2008) The p38 mitogen-activated protein kinase augments nucleotide excision repair by mediating DDB2 degradation and chromatin relaxation. J. Biol. Chem. 283, 32553-32561
119. Rampalli, S., Li, L., Mak, E., Ge, K., Brand, M., Tapscott, S. J. and Dilworth, F. J. (2007) p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat. Struct. Mol. Biol. 14, 1150-1156
120. Rao, P. S., Satelli, A., Zhang, S., Srivastava, S. K., Srivenugopal, K. S. and Rao, U. S. (2009) RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways. Proteomics 9, 2776-2787
121. Lluis, F., Perdiguero, E., Nebreda, A. R. and Muñoz-Canoves, P. (2006) Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 16, 36-44
122. Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I. and Zhao, K. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837
123. Cui, K., Zang, C., Roh, T. Y., Schones, D. E., Childs, R. W., Peng, W. and Zhao, K. (2009) Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4, 80-93
124. Wong, M. M., Cox, L. K. and Chrivia, J. C. (2007) The chromatin remodeling protein, SRCAP, is critical for deposition of the histone variant H2A.Z at promoters. J. Biol. Chem. 282, 26132-26139
125. Cuadrado, A., Lafarga, V., Cheung, P. C., Dolado, I., Llanos, S., Cohen, P. and Nebreda, A. R. (2007) A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J. 26, 2115-2126
126. Hamlet mediates different p53-dependent responses to DNA-damage inducing agents. Cell Cycle 6, 2319-2322
127. Hamlet/SRCAP-mediated histone H2A.Z chromatin incorporation in muscle differentiation. EMBO J., doi:10.1038/emboj.2010.85
128. Junttila, M. R., Li, S. P. and Westermarck, J. (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22, 954-965 (Pubitemid 351519953)
129. Wagner, E. F. and Nebreda, A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
130. Vermeulen, L., De Wilde, G., Van Damme, P., Vanden Berghe, W. and Haegeman, G. (2003) Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22, 1313-1324
131. Kefaloyianni, E., Gaitanaki, C. and Beis, I. (2006) ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-κB transactivation during oxidative stress in skeletal myoblasts. Cell. Signalling 18, 2238-2251
132. Chew, J., Biswas, S., Shreeram, S., Humaidi, M., Wong, E. T., Dhillion, M. K., Teo, H., Hazra, A., Fang, C. C., Lopez-Collazo, E. et al. (2009) WIP1 phosphatase is a negative regulator of NF-κB signalling. Nat. Cell Biol. 11, 659-666
133. Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B. and Rincon, M. (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3β inactivation. Science 320, 667-670
134. Abell, A. N., Granger, D. A. and Johnson, G. L. (2007) MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3β. J. Biol. Chem. 282, 30476-30484
135. Yuan, Z. Q., Feldman, R. I., Sussman, G. E., Coppola, D., Nicosia, S. V. and Cheng, J. Q. (2003) AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J. Biol. Chem. 278, 23432-23440
136. Kim, M. A., Kim, H. J., Jee, H. J., Kim, A. J., Bae, Y. S., Bae, S. S. and Yun, J. (2009) Akt2, but not Akt1, is required for cell survival by inhibiting activation of JNK and p38 after UV irradiation. Oncogene 28, 1241-1247
137. Zuluaga, S., Alvarez-Barrientos, A., Gutierrez-Uzquiza, A., Benito, M., Nebreda, A. R. and Porras, A. (2007) Negative regulation of Akt activity by p38α MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1. Cell. Signalling 19, 62-74
138. Seimon, T. A., Wang, Y., Han, S., Senokuchi, T., Schrijvers, D. M., Kuriakose, G., Tall, A. R. and Tabas, I. A. (2009) Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J. Clin. Invest. 119, 886-898
139. Wu, R., Kausar, H., Johnson, P., Montoya-Durango, D. E., Merchant, M. and Rane, M. J. (2007) Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J. Biol. Chem. 282, 21598-21608
140. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185
141. Dolado, I. and Nebreda, A. R. (2008) Regulation of tumorigenesis by p38α MAP kinase. Top. Curr. Genet. 20, 99-128
142. Haq, R., Brenton, J. D., Takahashi, M., Finan, D., Finkielsztein, A., Damaraju, S., Rottapel, R. and Zanke, B. (2002) Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 62, 5076-5082
143. Puri, P. L., Wu, Z., Zhang, P., Wood, L. D., Bhakta, K. S., Han, J., Feramisco, J. R., Karin, M. and Wang, J. Y. (2000) Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14, 574-584
144. Ambrosino, C., Mace, G., Galban, S., Fritsch, C., Vintersten, K., Black, E., Gorospe, M. and Nebreda, A. R. (2003) Negative feedback regulation of MKK6 mRNA stability by p38α mitogen-activated protein kinase. Mol. Cell. Biol. 23, 370-381
145. Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R. and Nebreda, A. R. (2000) Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6, 109-116
146. Mudgett, J. S., Ding, J., Guh-Siesel, L., Chartrain, N. A., Yang, L., Gopal, S. and Shen, M. M. (2000) Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 97, 10454-10459
147. Tamura, K., Sudo, T., Senftleben, U., Dadak, A. M., Johnson, R. and Karin, M. (2000) Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102, 221-231
148. Lu, H. T., Yang, D. D., Wysk, M., Gatti, E., Mellman, I., Davis, R. J. and Flavell, R. A. (1999) Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18, 1845-1857
149. Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M. and Nebreda, A. R. (2007) p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39, 750-758
150. Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H. and Wagner, E. F. (2007) p38α suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat. Genet. 39, 741-749
151. Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., Jiang, H., Wang, Y. and Keating, M. T. (2005) p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 19, 1175-1187
152. Kang, Y. J., Chen, J., Otsuka, M., Mols, J., Ren, S., Wang, Y. and Han, J. (2008) Macrophage deletion of p38α partially impairs lipopolysaccharide-induced cellular activation. J. Immunol. 180, 5075-5082
153. Kim, C., Sano, Y., Todorova, K., Carlson, B. A., Arpa, L., Celada, A.,
154. Sakurai, T., He, G., Matsuzawa, A., Yu, G. Y., Maeda, S., Hardiman, G. and Karin, M. (2008) Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14, 156-165
155. MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age. Dev. Cell 17, 142-149
156. Beardmore, V. A., Hinton, H. J., Eftychi, C., Apostolaki, M., Armaka, M., Darragh, J., McIlrath, J., Carr, J. M., Armit, L. J., Clacher, C. et al. (2005) Generation and characterization of p38β (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25, 10454-10464
157. Sumara, G., Formentini, I., Collins, S., Sumara, I., Windak, R., Bodenmiller, B., Ramracheya, R., Caille, D., Jiang, H., Platt, K. A. et al. (2009) Regulation of PKD by the MAPK p38δ in insulin secretion and glucose homeostasis. Cell 136, 235-248
158. Schindler, E. M., Hindes, A., Gribben, E. L., Burns, C. J., Yin, Y., Lin, M. H., Owen, R. J., Longmore, G. D., Kissling, G. E., Arthur, J. S. and Efimova, T. (2009) p38δ Mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res. 69, 4648-4655
159. Gillespie, M. A., Le Grand, F., Scime, A., Kuang, S., von Maltzahn, J., Seale, V., Cuenda, A., Ranish, J. A. and Rudnicki, M. A. (2009) p38γ-dependent gene silencing restricts entry into the myogenic differentiation program. J. Cell Biol. 187, 991-1005
160. Kumar, S., Boehm, J. and Lee, J. C. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717-726
161. MAPK: stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 15, 369-379
162. Cohen, P. (1997) The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7, 353-361
163. Eyers, P. A., Craxton, M., Morrice, N., Cohen, P. and Goedert, M. (1998) Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. Chem. Biol. 5, 321-328
164. Gum, R. J., McLaughlin, M. M., Kumar, S., Wang, Z., Bower, M. J., Lee, J. C., Adams, J. L., Livi, G. P., Goldsmith, E. J. and Young, P. R. (1998) Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J. Biol. Chem. 273, 15605-15610
165. Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P., Blencke, S., Gutbrod, H., Salassidis, K., Stein-Gerlach, M., Missio, A., Cotten, M. and Daub, H. (2003) An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 100, 15434-15439
166. Fabian, M. A., Biggs, 3rd, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M. et al. (2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat. Biotechnol. 23, 329-336
167. Xing, L., Shieh, H. S., Selness, S. R., Devraj, R. V., Walker, J. K., Devadas, B., Hope, H. R., Compton, R. P., Schindler, J. F., Hirsch, J. L. et al. (2009) Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804. Biochemistry 48, 6402-6411
168. Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S. and Regan, J. (2002) Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 9, 268-272
169. Perry, J. J., Harris, R. M., Moiani, D., Olson, A. J. and Tainer, J. A. (2009) p38α MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses. J. Mol. Biol. 391, 1-11
170. Mayer, R. J. and Callahan, J. F. (2006) p38 MAP kinase inhibitors: a future therapy for inflammatory diseases. Drug Discov. Today 3, 49-54
171. Sy, J. C., Seshadri, G., Yang, S. C., Brown, M., Oh, T., Dikalov, S., Murthy, N. and Davis, M. E. (2008) Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat. Mater. 7, 863-868
172. Gaestel, M. and Kracht, M. (2009) Peptides as signaling inhibitors for mammalian MAP kinase cascades. Curr. Pharm. Des. 15, 2471-2480